Condensed Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2019	Jun. 30, 2018
Cash flows from operating activities:
Net income (loss)	$ (37,517)	$ (17,501)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Loss from Equity Method Investment in the Joint Venture	39,554	22,766
Deferred income tax expense (benefit)	(2,184)	(4,801)
(Gain) Loss on Sale of Interests in the Joint Venture		(464)
Changes in operating assets and liabilities:
Due from the Joint Venture	(201)	(31)
Income taxes receivable	180	(208)
Accrued expenses	168	31
Due to the Joint Venture		208
Net cash provided by (used in) operating activities
Cash flows from investing activities:
Proceeds from sale of interests in Joint Venture		4,782
Net cash provided by (used in) investing activities		4,782
Cash flows from financing activities:
Payments to acquire common stock		(4,782)
Net cash provided by (used in) financing activities		(4,782)
Net increase (decrease) in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash at beginning of period	3,409
Cash, cash equivalents and restricted cash at end of period	$ 3,409